But retail lost over 95% value in the last 15 years. They are all pretty much wiped off!
There will be no generational wealth as neither big pharma nor big, credible institutional investors see value in NWBO. Even LP thinks it’s worth .22 per the latest dilution. Endless dilution in pennies to continue. So be prepared to average down year after year, LOL!
Slave1 you stated: "Tissue-in, immune-out. Not just for glioblastoma. For dozens of solid tumors. Across regulatory pathways. Across markets." Well take a look at this. Competition gaining ground.